At a mechanistic level, our data underscore that ARPC1B promotes ccRCC advancement through stimulation of EMT, an essential mechanism underlying tumor invasion and metastatic capability [35–37]. The gene discussed is ARPC1B; the disease is nonpapillary renal cell carcinoma.